ACE and myocardial infarction: Angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin-II type1 receptor blocker (ARB), key drugs for renin-angiotensin-aldosterone system (RAAS) blockade, are widely used in clinical practice for managing arterial hypertension, heart failure, myocardial infarction, and chronic kidney disease without any serious adverse effects.